Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical tissue ischaemia in scleroderma: a note of caution.

Literature DB >> 8017980

Critical tissue ischaemia in scleroderma: a note of caution.

J R Seibold¹.

Abstract

Entities: Disease

Mesh：

Year: 1994 PMID： 8017980 PMCID： PMC1005322 DOI： 10.1136/ard.53.5.289

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

15 in total

1. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.

Authors: B Marasini; M Cugno; A Agostoni
Journal: Arthritis Rheum Date: 1991-02

2. Elevated plasma levels of endothelin-1 in systemic sclerosis.

Authors: K Yamane; H Kashiwagi; N Suzuki; T Miyauchi; M Yanagisawa; K Goto; T Masaki
Journal: Arthritis Rheum Date: 1991-02

3. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin".

Authors: H N Claman; R C Giorno; J R Seibold
Journal: Arthritis Rheum Date: 1991-12

4. Normotensive renal failure in systemic sclerosis.

Authors: D J Helfrich; B Banner; V D Steen; T A Medsger
Journal: Arthritis Rheum Date: 1989-09

5. Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis.

Authors: A L Herrick; P Oogarah; T B Brammah; A J Freemont; M I Jayson
Journal: Ann Rheum Dis Date: 1994-05 Impact factor: 19.103

6. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

Authors: E L Alexander; G S Firestein; J L Weiss; R R Heuser; G Leitl; H N Wagner; J A Brinker; A A Ciuffo; L C Becker
Journal: Ann Intern Med Date: 1986-11 Impact factor: 25.391

7. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

Authors: P J Cannon; M Hassar; D B Case; W J Casarella; S C Sommers; E C LeRoy
Journal: Medicine (Baltimore) Date: 1974-01 Impact factor: 1.889

Review 8. Serotonin and Raynaud's phenomenon.

Authors: J R Seibold
Journal: J Cardiovasc Pharmacol Date: 1985 Impact factor: 3.105

Critical tissue ischaemia in scleroderma: a note of caution.

1. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.

2. Elevated plasma levels of endothelin-1 in systemic sclerosis.

3. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin".

4. Normotensive renal failure in systemic sclerosis.

5. Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis.

6. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

7. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

Review 8. Serotonin and Raynaud's phenomenon.

9. Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis.

10. Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant.

1. Increased capillary permeability in systemic sclerosis: help or hindrance?

Review 2. Evidence-based management of Raynaud's phenomenon.